Progression and Treatment Outcomes of Lung Disease Caused byMycobacterium abscessusandMycobacterium massiliense

Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease

(2016) Won-Jung Koh et al.   CHEST

The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea

(2015) Song Yee Kim et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis

(2015) Giulia Bonaiti et al.   Biomed Research International

Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease

(2014) Richard J. Wallace et al.   CHEST

Mycobacterium abscessus

(2014) Jeana L. Benwill et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Advances in the management of pulmonary disease due to Mycobacterium abscessus complex

(2014) W-J. Koh et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease

(2014) Jiwon Lyu et al.   RESPIRATORY MEDICINE

Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease

(2013) Meng-Rui Lee et al.   PLoS One

Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials

(2013) Timothy R. Aksamit et al.   RESPIRATORY MEDICINE

Macrolide Treatment forMycobacterium abscessusandMycobacterium massilienseInfection and Inducible Resistance

(2012) Go-Eun Choi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries

(2012) Jennifer Adjemian et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Significance of the Differentiation Between Mycobacterium avium and Mycobacterium intracellulare in M avium Complex Lung Disease

(2012) Won-Jung Koh et al.   CHEST

Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria

(2012) B. A. Brown-Elliott et al.   CLINICAL MICROBIOLOGY REVIEWS

Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease

(2012) S. Kitada et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases

(2012) T. Harada et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Serial CT Findings ofMycobacterium massiliensePulmonary Disease Compared withMycobacterium abscessusDisease after Treatment with Antibiotic Therapy

(2012) Hyun Su Kim et al.   RADIOLOGY

Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease

(2011) Julie Jarand et al.   CLINICAL INFECTIOUS DISEASES

Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs

(2011) Jiwon Lyu et al.   RESPIRATORY MEDICINE

Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems

(2010) D. Rebecca Prevots et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Significance of Differentiation ofMycobacterium massiliensefromMycobacterium abscessus

(2010) Won-Jung Koh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Antibiotic Treatment ofMycobacterium abscessusLung Disease

(2009) Kyeongman Jeon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results

(2009) C. Crim et al.   EUROPEAN RESPIRATORY JOURNAL

Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes

(2009) Xiugong Gao et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS